ADMS Adamas Pharmaceuticals Inc.

6.17
-0.11  -2%
Previous Close 6.28
Open 6.27
Price To Book 1.89
Market Cap 169343799
Shares 27,448,990
Volume 75,465
Short Ratio
Av. Daily Volume 613,312

NewsSee all news

  1. Adamas Announces New Employment Inducement Grant
  2. Edited Transcript of ADMS earnings conference call or presentation 4-Mar-19 9:30pm GMT
  3. Why Adamas Pharmaceuticals Shares Are Crashing Today
  4. The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings
  5. Adamas Pharmaceuticals Inc (ADMS) Q4 2018 Earnings Conference Call Transcript

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1b top-line data released September 7, 2017. Pivotal Phase 3 trial to be initiated 2019.
ADS-4101
Partial onset seizures in patents with epilepsy
Phase 3 data due 2H 2019.
GOCOVRI (amantadine)
Multiple sclerosis (MS)
Approved December, 24 2014.
Namzaric
Moderate to severe dementia of the Alzheimer's type.
Approval announced August 24, 2017.
ADS-5102
Levodopa-Induced Dyskinesia
Phase 3 open-label data released April 19, 2018.
GOCOVRI (amantadine)
Dyskinesia patients with Parkinson's disease

Latest News

  1. Adamas Announces New Employment Inducement Grant
  2. Edited Transcript of ADMS earnings conference call or presentation 4-Mar-19 9:30pm GMT
  3. Why Adamas Pharmaceuticals Shares Are Crashing Today
  4. The Daily Biotech Pulse: Novartis Psoriasis Drug Found Superior, Ascendis Offering, Adamas Earnings
  5. Adamas Pharmaceuticals Inc (ADMS) Q4 2018 Earnings Conference Call Transcript
  6. Adamas Reports Recent Achievements and Financial Results for the Fourth Quarter and Full-Year 2018
  7. Will R&D Focus Fuel DENTSPLY SIRONA's (XRAY) Earnings in Q4?
  8. Adamas Pharmaceuticals (ADMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
  9. Adamas to Present at Two Upcoming Investor Conferences
  10. Adamas to Announce Fourth Quarter and Year-End 2018 Financial Results and Host Conference Call on March 4, 2019
  11. Tenet Healthcare (THC) Q4 Earnings: What's in the Offing?
  12. Can Segmental Growth Fuel Veeva Systems' (VEEV) Q4 Earnings?
  13. AptarGroup (ATR) to Report Q4 Earnings: What's in Store?
  14. Should You Be Worried About Insider Transactions At Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS)?
  15. Is a Beat in Store for Molina Healthcare (MOH) Q4 Earnings?
  16. Report: Exploring Fundamental Drivers Behind Roku, AECOM, 1-800 FLOWERS.COM, Eldorado Resorts, Haverty Furniture Companies, and Adamas Pharmaceuticals — New Horizons, Emerging Trends, and Upcoming Developments
  17. LD Micro Welcomes Nearly 1,000 Companies to the LD Micro Index
  18. Here's Why These Small-Cap Pharma Stocks Lost as Much as 45% in December